Live Breaking News & Updates on அமீன் பார்மா ஆராய்ச்சி நிறுவனம்

Stay updated with breaking news from அமீன் பார்மா ஆராய்ச்சி நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Stroke of Luck: Therapeutic Target Discovered in Blood–Brain Barrier


 
Scientists from Japan and the United States have identified a new mechanism of blood-brain barrier degradation in the post-stroke brain, involving acrolein-induced modifications of proheparanase. This discovery could lead to the production of newer and more effective drugs for stroke-related disorders. Credit: Toubibe from Pixabay
Read Time:
The blood-brain barrier prevents immune cells from circulating freely in the brain, and the breakdown of its function is a major cause of post-stroke inflammation. Now, for the first time, researchers have identified how a toxic stroke byproduct, acrolein, could activate the barrier-degrading enzyme proheparanase (proHPSE). The research group has discovered that proHPSE degrades the glycocalyx within the post-stroke brain s blood vessels, providing hope for new and effective therapeutics against post-stroke inflammation. ....

United States , Kazuei Igarashi , Tomomi Furihata , Takehiro Suzuki , Toshihiko Toida , Kyohei Higashi , Naoshi Dohmae , Robertj Linhardt , Tokyo University Of Pharmacy , Amine Pharma Research Institute , Rensselaer Polytechnic Institute , Life Sciences , Tokyo University Of Science , Chiba University , Associate Professor Kyohei Higashi , Tokyo University , Biological Chemistry , Sustainable Resource Science , ஒன்றுபட்டது மாநிலங்களில் , டோக்கியோ பல்கலைக்கழகம் ஆஃப் மருந்தகம் , அமீன் பார்மா ஆராய்ச்சி நிறுவனம் , ரென்சீலர் பாலிடெக்நிக் நிறுவனம் , வாழ்க்கை அறிவியல் , டோக்கியோ பல்கலைக்கழகம் ஆஃப் அறிவியல் , சிபா பல்கலைக்கழகம் , டோக்கியோ பல்கலைக்கழகம் ,

Stroke of luck: Scientists discover target for stroke therapy in blood-brain barrier


 E-Mail
IMAGE: Scientists from Japan and the United States have identified a new mechanism of blood-brain barrier degradation in the post-stroke brain, involving acrolein-induced modifications of proheparanase. This discovery could lead to.
view more 
Credit: Toubibe from Pixabay
Strokes are a leading cause of poor quality of life or even death in Japan and the world over. Since its characterization, several researchers have been working tooth and nail to identify drug-accessible and effective therapeutic targets for this debilitating condition. One such region of interest for drug targets is the blood-brain barrier (BBB).
The BBB is a structure located around the brain, which prevents the entry of unnecessary circulating cells and biomolecules into the brain. The blood vessels in the BBB are coated with a distinct and protective layer of sugar, called the endothelial glycocalyx, which prevents their entry. However, in the event of a stroke, which res ....

United States , Kazuei Igarashi , Tomomi Furihata , Takehiro Suzuki , Toshihiko Toida , Kyohei Higashi , Naoshi Dohmae , Robertj Linhardt , Tokyo University Of Pharmacy , Amine Pharma Research Institute , Rensselaer Polytechnic Institute , Life Sciences , Tokyo University Of Science , Chiba University , Associate Professor Kyohei Higashi , Tokyo University , Biological Chemistry , Sustainable Resource Science , Nobel Prize , Junior Associate Professor , Cell Biology , Medicine Health , Clinical Trials , Health Care Systems Services , Internal Medicine , Metabolism Metabolic Diseases ,